105 related articles for article (PubMed ID: 2809696)
1. Combined chemotherapy for recurrent and metastatic nasopharyngeal carcinoma.
Airoldi M; Pedani F; Gabriele P; Giordano C; Cavalot A; Brando V
J Chemother; 1989 Aug; 1(4):272-6. PubMed ID: 2809696
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.
Hasbini A; Mahjoubi R; Fandi A; Chouaki N; Taamma A; Lianes P; Cortès-Funes H; Alonso S; Armand JP; Cvitkovic E; Raymond E
Ann Oncol; 1999 Apr; 10(4):421-5. PubMed ID: 10370784
[TBL] [Abstract][Full Text] [Related]
3. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
5. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
[TBL] [Abstract][Full Text] [Related]
6. Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis.
Lin JC; Jan JS; Hsu CY
Cancer; 1998 Aug; 83(4):635-40. PubMed ID: 9708925
[TBL] [Abstract][Full Text] [Related]
7. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01).
Ji JH; ; Yun T; Kim SB; Kang JH; Park JC; Cho IS; Sohn CH; Heo DS; Jang JS; Shin SW; Hwang DW; Sun JM; Park K; Ahn MJ
Eur J Cancer; 2012 Nov; 48(17):3198-204. PubMed ID: 22795584
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy with cisplatin and continuous infusion of 5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan.
Su WC; Chen TY; Kao RH; Tsao CJ
Oncology; 1993; 50(4):205-8. PubMed ID: 7684518
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Kua VF; Ismail F; Chee Ee Phua V; Aslan NM
Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.
Gebbia V; Zerillo G; Restivo G; Speciale R; Cupido G; Lo Bue P; Ingria F; Gallina S; Spatafora G; Testa A
Br J Cancer; 1993 Jul; 68(1):191-4. PubMed ID: 7686391
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma.
Hsieh CH; Hsu CL; Wang CH; Liaw CC; Chen JS; Chang HK; Yang TS; Chang JW; Lin YC; Liau CT; Tsang NM; Chang JT; Ng SH; Wang HM
Biomed J; 2013; 36(5):229-36. PubMed ID: 24225189
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
Boussen H; Cvitkovic E; Wendling JL; Azli N; Bachouchi M; Mahjoubi R; Kalifa C; Wibault P; Schwaab G; Armand JP
J Clin Oncol; 1991 Sep; 9(9):1675-81. PubMed ID: 1714951
[TBL] [Abstract][Full Text] [Related]
14. Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma.
Chen C; Wang FH; An X; Luo HY; Wang ZQ; Liang Y; Zhang L; Li YH
Cancer Chemother Pharmacol; 2013 Feb; 71(2):371-8. PubMed ID: 23143190
[TBL] [Abstract][Full Text] [Related]
15. Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
Peng H; Chen L; Li WF; Guo R; Mao YP; Zhang Y; Guo Y; Sun Y; Ma J
Cancer; 2017 May; 123(9):1643-1652. PubMed ID: 28001301
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
[TBL] [Abstract][Full Text] [Related]
17. Excellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma.
Al-Kourainy K; Crissman J; Ensley J; Kish J; Kelly J; Al-Sarraf M
Am J Clin Oncol; 1988 Aug; 11(4):427-30. PubMed ID: 2457306
[TBL] [Abstract][Full Text] [Related]
18. Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.
Peng PJ; Ou XQ; Chen ZB; Liao H; Peng YL; Wang SY; Zhang HY; Lin Z
Cancer Chemother Pharmacol; 2013 Aug; 72(2):323-8. PubMed ID: 23728706
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma.
Dimery IW; Legha SS; Peters LJ; Goepfert H; Oswald MJ
Cancer; 1987 Sep; 60(5):943-9. PubMed ID: 3607731
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma.
Yau TK; Shum T; Lee AW; Yeung MW; Ng WT; Chan L
Oral Oncol; 2012 May; 48(5):441-4. PubMed ID: 22206807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
